Advertisement

Journal of Gastrointestinal Surgery

, Volume 12, Issue 7, pp 1177–1184 | Cite as

Diagnostic Laparoscopy for Patients with Potentially Resectable Pancreatic Adenocarcinoma: Is It Cost-Effective in the Current Era?

  • C. K. Enestvedt
  • S. C. Mayo
  • B. S. Diggs
  • M. Mori
  • D. A. Austin
  • D. K. Shipley
  • B. C. Sheppard
  • K. G. BillingsleyEmail author
ahpba annual meeting

Abstract

Introduction

For patients with potentially resectable pancreatic cancer, diagnostic laparoscopy may identify liver and peritoneal metastases that are difficult to detect with other staging modalities. The aim of this study was to utilize a population-based pancreatic cancer database to assess the cost effectiveness of preoperative laparoscopy.

Material and Methods

Data from a state cancer registry were linked with primary medical record data for years 1996–2003. De-identified patient records were reviewed to determine the role and findings of laparoscopic exploration. Average hospital and physician charges for laparotomy, biliary bypass, pancreaticoduodenectomy, and laparoscopy were determined by review of billing data from our institution and Medicare data for fiscal years 2005–2006. Cost-effectiveness was determined by comparing three methods of utilization of laparoscopy: (1) routine (all patients), (2) case-specific, and (3) no utilization.

Results and Discussion

Of 298 potentially resectable patients, 86 underwent laparoscopy. The prevalence of unresectable disease was 14.1% diagnosed at either laparotomy or laparoscopy. The mean charge per patient for routine, case-specific, and no utilization of laparoscopy was $91,805, $90,888, and $93,134, respectively.

Conclusion

Cost analysis indicates that the case-specific or routine use of laparoscopy in pancreatic cancer does not add significantly to the overall expense of treatment and supports the use of laparoscopy in patients with known or suspected pancreatic adenocarcinoma.

Keywords

Pancreatic cancer Laparoscopy Diagnostic laparoscopy Cost-effective 

Notes

Acknowledgments

The authors wish to thank Dr. Charles Vollmer for his generous assistance in the preparation of this manuscript.

References

  1. 1.
    National Cancer Institute. Surveillance, epidemiology, and end results (SEER) registries; 2006.Google Scholar
  2. 2.
    Du W, Touchette D, Vaitkevicius VK et al. Cost analysis of pancreatic carcinoma treatment. Cancer 2000;89(9):1917–24.PubMedCrossRefGoogle Scholar
  3. 3.
    Chang S, Long SR, Kutikova L et al. Burden of pancreatic cancer and disease progression: economic analysis in the US. Oncology 2006;70(1):71–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Yeo CJ, Abrams RA, Grochow LB et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997;225(5):621–33, discussion 633–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Beger HG, Rau B, Gansauge F et al. Treatment of pancreatic cancer: challenge of the facts. World J Surg. 2003;27(10):1075–84.PubMedCrossRefGoogle Scholar
  6. 6.
    Yovino S, Darwin P, Daly B et al. Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound. J Gastrointest Surg. 2007;11(1):36–42.PubMedCrossRefGoogle Scholar
  7. 7.
    Menack MJ, Spitz JD, Arregui ME. Staging of pancreatic and ampullary cancers for resectability using laparoscopy with laparoscopic ultrasound. Surg Endosc. 2001;15(10):1129–34.PubMedCrossRefGoogle Scholar
  8. 8.
    Jimenez RE, Warshaw AL, Rattner DW et al. Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg. 2000;135(4):409–14, discussion 414–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Hochwald SN, Weiser MR, Colleoni R et al. Laparoscopy predicts metastatic disease and spares laparotomy in selected patients with pancreatic nonfunctioning islet cell tumors. Ann Surg. Oncol 2001;8(3):249–53.PubMedCrossRefGoogle Scholar
  10. 10.
    Friess H, Kleeff J, Silva JC et al. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies. J Am Coll Surg. 1998;186(6):675–82.PubMedCrossRefGoogle Scholar
  11. 11.
    Pisters PW, Lee JE, Vauthey JN et al. Laparoscopy in the staging of pancreatic cancer. Br J Surg. 2001;88(3):325–37.PubMedCrossRefGoogle Scholar
  12. 12.
    AMA. Current procedural terminology. Chicago: American Medical Association, 2004.Google Scholar
  13. 13.
    AMA. International Cclassification of diseases-9. 9th ed. Chicago: American Medical Association, 2004.Google Scholar
  14. 14.
    CMS. Diagnosis related group definitions manual. Centers for Medicare and Medicaid Services; 2005.Google Scholar
  15. 15.
    CMS. Physician fee schedule search. US Department of Health and Human Services; 2006.Google Scholar
  16. 16.
    Reddy KR, Levi J, Livingstone A et al. Experience with staging laparoscopy in pancreatic malignancy. Gastrointest Endosc. 1999;49(4 Pt 1):498–503.PubMedCrossRefGoogle Scholar
  17. 17.
    Karachristos A, Scarmeas N, Hoffman JP. CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer. J Gastrointest Surg. 2005;9(9):1286–92.PubMedCrossRefGoogle Scholar
  18. 18.
    Conlon KC, Dougherty E, Klimstra DS et al. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg. 1996;223(2):134–40.PubMedCrossRefGoogle Scholar
  19. 19.
    Espat NJ, Brennan MF, Conlon KC. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg. 1999;188(6):649–55, discussion 655–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Liu RC, Traverso LW. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc. 2005;19(5):638–42.PubMedCrossRefGoogle Scholar
  21. 21.
    Vollmer CM, Drebin JA, Middleton WD et al. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg. 2002;235(1):1–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Andren-Sandberg A, Lindberg CG, Lundstedt C, Ihse I. Computed tomography and laparoscopy in the assessment of the patient with pancreatic cancer. J Am Coll Surg. 1998;186(1):35–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Stefanidis D, Grove KD, Schwesinger WH, Thomas CR Jr. The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol. 2006;17(2):189–99.PubMedCrossRefGoogle Scholar
  24. 24.
    Tierney WM, Fendrick AM, Hirth RA, Scheiman JM. The clinical and economic impact of alternative staging strategies for adenocarcinoma of the pancreas. Am J Gastroenterol. 2000;95(7):1708–13.PubMedCrossRefGoogle Scholar
  25. 25.
    Canales MG, Macario A, Krummel T. The surgical suite meets the new health economy. J Am Coll Surg. 2001;192(6):768–76.PubMedCrossRefGoogle Scholar
  26. 26.
    McCahill LE, Pellegrini CA, Wiggins T, Helton WS. A clinical outcome and cost analysis of laparoscopic versus open appendectomy. Am J Surg. 1996;171(5):533–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Dorsey JH, Holtz PM, Griffiths RI et al. Costs and charges associated with three alternative techniques of hysterectomy. N Engl J Med. 1996;335(7):476–82.PubMedCrossRefGoogle Scholar
  28. 28.
    Luks FI, Logan J, Breuer CK et al. Cost-effectiveness of laparoscopy in children. Arch Pediatr Adolesc Med. 1999;153(9):965–8.PubMedGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2008

Authors and Affiliations

  • C. K. Enestvedt
    • 1
  • S. C. Mayo
    • 2
  • B. S. Diggs
    • 1
  • M. Mori
    • 3
    • 4
  • D. A. Austin
    • 4
  • D. K. Shipley
    • 5
  • B. C. Sheppard
    • 1
  • K. G. Billingsley
    • 1
    • 6
    Email author
  1. 1.Department of SurgeryOregon Health & Science UniversityPortlandUSA
  2. 2.Department of SurgeryJohns Hopkins HospitalBaltimoreUSA
  3. 3.Department of BiostatisticsOregon Health & Science UniversityPortlandUSA
  4. 4.Department of Public Health and Preventive MedicineOregon Health & Science UniversityPortlandUSA
  5. 5.Oregon State Cancer RegistryPortlandUSA
  6. 6.Division of Surgical OncologyOregon Health & Science UniversityPortlandUSA

Personalised recommendations